lence of hyponatremia ranges from 9.4 to 15% in hospitalized patients [2, 3] and is particularly high among patients from nursing homes and all elderly persons [4] . The clinical symptoms are closely related to the severity and onset of hyponatremia.
The acute form is defined by an occurrence of clinical symptoms within ! 48 h and is due to severe hyponatremia. A pronounced lowering of serum sodium levels increases the risk for intracranial hypertension and severe neurological symptoms [5] .
In contrast to this critical situation, mild stable hyponatremia -defined as a serum sodium level of 120-132 mmol/l -is generally considered to be clinically asymptomatic. However, several studies reported functional impairments in elderly patients under this condition. Renneborg et al. [1] determined the fall frequency in 122 patients with chronic hyponatremia and 244 controls, who were admitted to a medical emergency department. In this study, significantly more hyponatremic patients were admitted to hospital because of falls (21.3%) than patients in the control group with normal sodium values (5.3%) (p ! 0.001). Gait and attention were also significantly impaired.
Decaux [6] applied attention and gait tests to assess physical function in 16 patients with asymptomatic hyponatremia (serum sodium 128 8 3 mmol/l) resulting from inappropriate antidiuretic hormone secretion. Attention and gait were even more severely impaired in the patients than in age-matched volunteers who ingested 0.55 g alcohol per kg bodyweight before the performance of the tests.
Hyponatremia is also known as a risk factor for bone fractures in elderly [7] . The study by Sandhu et al. [8] demonstrated an association of lower sodium levels to the incidence of larger bone fractures in elderly patients. The frequency of falls was found to be not increased in patients with severe compared to mild hyponatremia [9] .
A further aspect that has to be considered in the complex consequences of hyponatremia is the impaired nerve conduction velocity [10] , which could affect balance regulation.
Overall, the prevention of falls in elderly has become a major public health interest. The elderly population is increasing, which is paralleled by an increase in the need for care facilities. Up to 5% of older people who fall require subsequent hospitalization. Gait and balance deficits, as well as cognitive impairments are known as independent fall risk factors, but also as clinical symptoms of hyponatremia [6, 11] .
Drugs are a common cause of electrolyte abnormalities and one of the more common electrolyte abnormalities that may be drug induced is hyponatremia [12, 13] . Drugs may cause mainly hyponatremia by affecting sodium and water homeostasis [12] like diuretics [14] or increasing the hypothalamic production of ADH [12] like antidepressants [12, 15] , antipsychotic drugs [16] , antiepileptic drugs [17] [18] [19] and opioide therapy [20] .
The Comprehensvie Geriatric Assessment (CGA) is a standardized tool to screen for functional and cognitive disabilities, depression, delirium and malnutrition in elderly patients. It can be defined as 'a multidimensional, usually interdisciplinary, diagnostic process intended to determine an older person's medical, psychosocial, and functional capacity and problems with the objective of developing an overall plan for treatment and long-term follow-up' [21] . It has been used for many years to evaluate and address the complex and special needs of frail hospitalized older patients. The results of the CGA reveal a strong relation to the prognostic outcome and thus have a significant impact on the treatment of elderly patients. Until now, only few published data are available concerning the association of laboratory results and the outcome in the CGA.
Considering the importance of the CGA in the therapy plan for elderly patients and the discrepant results in the literature about the influence of laboratory results on functional disabilities we performed a retrospective analysis in a cohort of elderly patients undergoing a CGA. A main purpose was to study the association of mild-tomoderate hyponatremia to the results of standardized tests of the CGA.
Methods

Study Design
The present study is a retrospective case-control study. Data were collected between 2005/07/05 and 2008/01/07 at the Department of Geriatrics and Internal Medicine at the hospital of Hochzirl. The setting of our study corresponds to a Geriatric Evaluation and Management Unit (GEMU). The GEMU is 'a ward that admits frail older inpatients for a process of multidisciplinary assessment, review and therapy' [22] .
Study Population
We included all patients who were consecutively admitted to our department primarily or from another hospital or emergency department. All patients underwent standard clinical and laboratory tests (including glucose, CRP, sodium, potassium, calcium, chloride, creatinine, urea, GOT, GPT, ␥ -GT, urine status) and a CGA on the second day after admission to our hospital. Patients who were not able to perform the tests of the Geriatric Assessment (such as patients in life-threatening conditions, patients with the diagnosis of a pronounced cognitive impairment and palliative patients) were not included in the evaluation.
During the study period a total of 2,880 elderly patients with a mean age 78.6 8 6.98 years and a range of 65-102 years could be evaluated. All patients were assigned to 6 age groups from 65 up to 1 89 years in order to determine an age influence on the prevalence of mild to moderate hyponatremia. The results obtained in hyponatremic patients were compared to an aged-and sex-matched control group (n = 129, 79.1% female, 20.9% male, mean age 80.16 8 7.27 years; range 65 to 98 years) with normal sodium values (between 136 and 145 mmol/l).
Definition of Hyponatremia
According to literature, serum sodium levels from 131 to 118 mmol/l are defined as mild and moderate hyponatremia. The lowest sodium level observed in our study population was 118 mmol/l. Our evaluation was based on the threshold level of ^ 131 mmol/l for moderate hyponatremia in order to obtain an adequate number of patients for the study and to avoid a disproportionally high number of hyponatremic patients near to the standard value [3] . Patients with sodium levels higher than 145 mmol/l -indicating an underlying disorder for hypernatremia with a need for further diagnostic procedures -were excluded from our evaluation.
Data Collection Comorbidities and Further Results
To describe the diagnosis leading to hospital admission we used the International Classification of Diseases (ICD-10) ( table 1 ). The high prevalence of diseases of the musculoskeletal system and connective tissue (chapter XIII, ICD-codes M00-M99) and of injuries, poisoning and certain other consequences of external causes (chapter XIX, ICD-codes S00-T98) is a consequence of the high percentage of admissions from orthopedic and trauma surgery units.
In order to evaluate and graduate the comorbidities in the subgroups we applied the Charlson Comorbidities Index (CCI) [23] as well as the Cumulative Illness Rating Scale (CIRS) [24, 25] . For calculation of the scores all comorbidities registered in the formerly documented and actual case histories were considered.
A nonvalidated questionnaire for urinary incontinence symptoms with 6 items was used to screen for urinary incontinence [26] . A patient with 6 1 positive answer was classified as urinary incontinent. C-reactive protein values were determined in the blood samples obtained on the day of admission to our hospital.
Causes of Hyponatremia
We used the patients' charts to detect the causes of hyponatremia, looking for serumosmolarity and the diagnoses listed in the charts. We collected all diagnoses in connection with hyponatremia. a Recent surgical treatment: 'yes' means that a patient underwent surgery within 4 weeks before the admission to our GEMU.
Medication
Regarding the medication, the following substances were included (yes/no): nonsteroidal anti-inflammatory drugs, acetylsalicylic acid, thiazide diuretics, loop-diuretics, low potent neuroleptics, high potent neuroleptics, angiotensin-converting-enzyme (ACE) inhibitors, AT II blockers, tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRI), selective serotonin and noradrenalin reuptake inhibitors (SSNI), carbamazepine, quiinolones, spironolactone, monoaminoxidase inhibitors, vasopressin, amiloride, opiates, indapamide, oxacarbazepine, valproic acid, methotrexate, chemotherapeutics, lamotrigine, chlorpropamide, tolbutamide, venlafaxine, amlodipine, amiodarone, lorcainide, propafenone, theophylline, proton pump inhibitors, telipressine, bupropione. The selection of these substances was based on a literature review performed on PubMed concerning medication and hyponatremia. Furthermore, total number of medications (NOM) and number of potentially hyponatremiainducing medications (NOHIM) reported by the patient at admission were both evaluated.
Activities of Daily Living
To assess the overall functional status we used the activities of daily living (ADL), described by the Barthel Index [27] . Data were provided by a nurse, who had observed the patient for 24 h. The score ranges from 0 (dependent on assistance in daily activities (ADLs) such as bathing, eating and dressing) to 100 (independent) points. For the bivariate logistic regression model we defined patients with an ADL score of ! 75 points as relevant impairment in the activities of daily living.
Cognition and Depression
Two tests were applied to evaluate cognitive function, the Mini Mental State Examination (MMSE), a sufficient screening instrument for cognitive impairment, and the Clock Completion (CC) test, a sensitive test concerning practical cognitive skills [28, 29] . Patients with a MMSE score ! 28 and a CC score 1 3 were defined as cognitive impaired. Because of the fact that elderly patients with serious diseases often suffer from symptoms of depression [30] , we have applied the Geriatric Depression Scale (GDS) to screen for depressive disorders (short version) [31] . The short version contains 15 items, 1 5 positive answers are indicative for depression [31] .
Mobility and Risk of Falls
The Tinetti Performance-Oriented Mobility Assessment (POMA), also called the Tinetti Mobility Test (TMT), and the Timed Up&Go (TUG) are tools to determine impairments of mobility, gait and gait speed. The TMT predicts falls among elderly individuals; those scoring 20 to 24 of 28 on the TMT are at 'moderate' risk of falling, and individuals scoring ^ 19 are at 'high' risk of falling [32] . The TUG test of 6 20 s is a simple indicator of an older adult's impaired functional mobility [33] . It involves recording the time it takes the participant to stand up from a chair, walk 3 m, turn, walk back to the chair and sit down.
Nutrition
The nutritional status of the patients was determined by the Mini Nutritional Assessment (MNA) [34] . Added MNA score allows one to identify elderly who have an adequate nutritional status, those who are at risk of malnutrition and those who are malnourished. For our bivariate logistic regression we compared the patients with a MNA score ! 18 points.
All of the specific assessment tests were performed under the control of a nurse specialized for the geriatric test program.
Statistical Analysis
The SPSS version 20.0 (2011) was applied for statistical analysis. Metric scaled data are reported as arithmetic mean 8 SD and categorical data as absolute frequency and percentage distribution. Non parametric statistics (Mann-Whitney U test) were used since normality assumptions were not met for most of the outcome variables. Group effect and main condition effects were tested for significance by the Mann-Whitney U test and Wilcoxon signed rank test. The 2 test for independence was used to determine a possible relationship between two categorical variables. The significance level was defined by p ! 0.05. Multivariate logistic regression analyses were performed to identify factors associated with worse results in the CGA. The dependent variables for these analyses were the different tests of the CGA (ADL, MMSE, GDS, TMT, TUG, MNA, urinary incontinence). The independent variables were hyponatremia, age, recent surgical therapy, all items of the CCI and the CIRS, their total scores and the medication (as shown in table 2 ). Bivariate analyses were based on logistic regression to generate odds ratios (OR) and 95% CI. Independent variables were retained in the models when p ! 0.150.
Results
Overall a total of 2,880 patients with a mean age of 78.6 8 6.98 years (female 75.6%, male 24.4%) were included in our evaluation. 477 (16.7%) patients were hyponatremic (serum sodium ^ 135 mmol/l), 129 (4.5%) revealed mild or moderate hyponatremia (serum sodium 131-118 mmol/l). Thirty-two (1.1%) of 2,880 patients were hypernatremic. Patients with mild-to-moderate hyponatremia (female 79.1%, male 20.9%) had a mean age of 80.16 8 7.32 years and a mean sodium value of 127.98 mmol/l. The mean age of the normonatremic control group was 80.16 8 7.32 years (female 79.1%, male 20.9%) with a mean sodium value of 138 mmol/l. The prevalence of hyponatremia revealed peak values in the oldest age groups 6 85 years ( fig. 1 ). The increase in the prevalence of hyponatremia among these older age groups is significant (p = 0.004) ( table 3 shows the results of the CGA for each age group).
Comorbidities and Further Results
The calculated CCI revealed no significant difference (p = 0.208) between the hyponatremic patients (2.33 8 1.93) and the control group (2.01 8 1.97). Patients with hyponatremia had a higher prevalence of peripheral vascular disease (14 vs. 2.3%; p = 0.001), chronic lung disease (25.6 vs. 12.4%; p = 0.007) and connective tissue disease (1.6 vs. 8.5%; p = 0.010). Using the CIRS, we could not find a significant difference in the total score between the two groups. Respiratory problems were significantly more frequent in the hyponatremic than in the control group ( table 4 ) . Hyponatremic patients revealed symptoms of urinary incontinence more frequently than the control group (60.9 vs. 48.3%; p = 0.016). This finding was supported by the results of multivariate analysis, demonstrating a significantly a higher risk for urinary incontinence in hyponatremic patients (p = 0.003, OR 2.69, 95% CI 1. 39-5.20) . With respect to laboratory results, the mean C-reactive protein was significantly higher in patients with hyponatremia (2.39 8 3.24 mmol/l) compared to the control group (1.26 8 2.14 mmol/l in p ! 0.001).
Patients with hyponatremia needed a significantly longer hospital treatment (19.8 8 8.3 days) than those in the control group (16.8 8 8.9 days; p = 0.002). 
Causes of Hyponatremia
According to the retrospective study design, the information about the probable causes of hyponatremia was based on the case histories. Serum osmolarity was available from 8 patients (6.3%), 6 (4.7%) of these measurements were found to be hypo-osmolar and 2 (1.6%) normo-osmolar. For 99 patients (76.8%) the diagnosis at discharge from hospital offered no underlying disease responsible for hyponatremia.
Adverse drug reaction (ADR) was described as the most common reason for hyponatremia (20 cases, 15.5%). Further cases of hyponatremia were related with heart failure in 4 (3.1%), severe liver disease in 1 (0.8%), cancer in 2 (1.6%), adrenal insufficiency in 2 (1.6%) and syndrome of inappropriate antidiuretic hormone secretion in 1 (0.8%).
Medication
The NOM taken by a patient was significantly higher in the hyponatremic group (8.4 8 3.8) than in the control group (6.9 8 3.6) (p = 0.002). Also, the NOHIM taken by the patients of the hyponatremic group was significantly higher than in the control group (3.33 8 1.8 vs. 2.85 8 1.73) (p = 0.034). However, there were no significant differences regarding one single drug or medication group (like diuretics, neuroleptics, antidepressive and antiepileptic drugs). All details are shown in table 5 . In the multivariate analyses the effect of the different medications on the CGA was small and not significant. 
Cognitive Function and Depression
The MMSE scores of 129 (100%) hyponatremic patients were analyzed and the mean MMSE value was 26.05 8 3.64 points. In the control group data from 128 (99.2%) patients were available. The mean MMSE score was significantly higher in the control group (27.18 The CC test could be performed in 123 (95.4%) hyponatremic patients and in 127 (98.5%) of the controls. The mean score was 2.44 8 3.13 points in hyponatremic patients compared to 1.17 8 2.52 points in the control group. In the hyponatremic group only 80 patients (65%) were able to follow the test in a correct way, compared to 105 (82.7%) of the controls (cut-off of ! 4 points). The CC test results also revealed a significant positive association with age (p ! 0. Also, the GDS revealed a significant difference between hyponatremic and normonatremic patients. We evaluated a GDS score from 128 (98.5%) patients in the hyponatremic group and 127 (98.5%) in the control group. The mean GDS score was 4.34 8 2.6 points in the hyponatremic group and 3.2 8 2.2 points in the control group (p ! 0.001). Using a cut-off of 1 5 points, 34 hyponatremic patients revealed symptoms of depression, but only 15 patients of the control group (p = 0.003). Diabetes without complications (p = 0.048), psychiatric diseases (p = 0.007), the NOM (p = 0.009) as well as all antidepressive drugs (p = 0.028) and SSRIs (p = 0.034) were significantly related to the GDS score. After multivariate analysis only hyponatremia (p = 0.017, OR 2.57, 95% CI 1.19-5.55) and psychiatric diseases (p = 0.021, OR 1.86, 95% CI 1.10-3.15) remained as significant variables associated with the GDS.
Mobility 113 (87.6%) patients in the hyponatremic group were able to perform the TUG, as compared to 117 (90.7%) in the control group. Patients who are not able to perform these mobility tests are classified as immobile without the help of another person. Fourteen patients in the hyponatremic group, but only 6 in control group were found to be immobile. We could also observe a significant difference between hyponatremic and normonatremic patients in the performance of the TMT. In the hyponatremic group, 11 patients were not able to complete the test, which could be completed by all patients in the control group. The mean TMT score was 15. 
Discussion
The results of our present evaluation demonstrate that elderly patients with mild-to-moderate hyponatremiacompared to a control group with normal sodium levels -had a significantly worse outcome in cognitive and functional tests of the CGA. While previously published studies reported primarily the association of hyponatremia with a certain aspect of the geriatric assessment, especially mobility tests and the risk of falls [1, 6, 7] , we have applied a very comprehensive test battery including mobility, cognitive function and screening for depression and malnutrition. Significantly more patients with hyponatremia showed a worse outcome or either were not able to perform the cognitive and mobility tests. The mean ADL score in the hyponatremic patients was 69.3 compared to 87.6 in the control group (p ! 0.001). The severity of impairments found in our evaluation for patients with mild-to-moderate hyponatremia is thus relevant for daily living. Even in the multivariate analyses hyponatremia remained an independent predictor. Age had also a quite strong effect on the results. Other variables like comorbidities and medication showed only a weak and inconsistent association.
According to the literature, mild-to-moderate hyponatremia corresponded to a serum sodium level of 6 115 mmol/l. The prevalence of hyponatremia defined by sodium values ^ 135 mmol/l was 16.7% in our study population, which is in accordance to published studies [2, 3] , 4.5% of all patients revealed serum sodium values between ^ 131 and 6 118 mmol. The prevalence of hyponatremia increased with increasing age, which might be due to an increase in comorbidities and the impaired renal function as well as a higher risk of malnutrition. The factors responsible for the age-related changes in renal sodium handling are still incompletely defined. Glomerular filtration rate, physical factors determined in part by hemodynamics, the renin-aldosterone system and the atrial natriuretic peptide, are all determinants of renal sodium handling and each has been demonstrated to vary significantly with age [3] . Due to our retrospective study design we used serum creatinine as the only parameter to screen for renal failure, despite its well-known poor correlation with glomerular filtration rate [36] , especially in elderly people. In our evaluation the hyponatremic patients did not differ relating to the serum creatinine levels.
Furthermore, our results show that the relevance ofespecially mild -hyponatremia in clinical practice is underestimated. Specific laboratory tests were only done in 6.3% of the cases. A discharge diagnose in relationship to hyponatremia was found in one of four patients. These facts explain why we were not able to detect the reasons of hyponatremia in a sufficient way. Remarkable was the fact that ADRs were listed as the most common causes. This observation is in contrast to our findings concerning the medication. Some medications (e.g. diuretics) are taken more often by hyponatremic patients, but these differences were not significant. Our results are comparable with further studies [37, 38] . However, hyponatremic patients received significantly more medications, particularly more drugs that are known to cause hyponatremia.
There are few studies evaluating the role of drugs in the prevalence of hyponatremia in geriatric patients. Rosholm et al. [37] investigated the prevalence of hyponatremia in 332 very old nonhospitalised people focusing on drug use. In total, 19 persons had hyponatremia. Of the drugs generally known to cause hyponatremia, only omeprazole and oral antidiabetic agents were associated with significantly lower medium sodium concentrations. The only drug class associated with clinically relevant hyponatremia was thiazide diuretics, which was used by significantly more patients with hyponatremia. Severe hyponatremia was rarely seen and the authors concluded that drugs have only a limited influence on serum sodium concentration. Passare et al. [38] investigated the prevalence of hyponatremia and association with drug use in elderly people, coming to the conclusion that the prevalence of hyponatremia increases with age and that there is an association with carbamazepine, laxatives, diuretics and ACE-inhibitors.
On the one hand, the impact of medication to induce hyponatremia might be overestimated, on the other hand we have to be careful to interpret our results in regard to ADRs. ADRs are a well-known phenomenon but their incidence is quite rare and our study population might be too small to detect ADRs in a significant way. The fact that the total number of prescribed drugs is the most important risk factor of ADRs is already well described in the literature [39] .
Although the CCI did not differ significantly between patients with hyponatremia and the control group, hyponatremic patients were suffering more frequently from peripheral vascular disease, chronic lung disease and connective tissue disease. The CCI is a valid score to assess the overall comorbidities, but it does not estimate the severity of a single disease, for example in cases of heart failure. The CIRS evaluates not only the prevalence of different diseases in one individual; furthermore, it describes the problems caused by one or more diseases in one organ system. In our study we found in nearly all items no significant differences, with the exception of respiratory problems. Greenberg and Lehrich [40] found a higher mortality in hyponatremic patients suffering from cardiovascular, oncology and orthopedic diseases, but it remained unclear if hyponatremia itself leads to the higher mortality rate or if hyponatremia was just a marker for the severity of the diseases.
Our study reveals some limitations, especially with respect to the number of patients, and the fact, that only hospitalized patients were evaluated. No long-term observation data were available from the patients, in order to determine the influence of a normalized serum sodium level on functional outcome. Also the retrospective design which hinders the evaluation of causality of hyponatremia must be mentioned as limitation.
Despite these considerations we think that the results of our study are of clinical importance, regarding the interpretation of the CGA and consequences on ADL as well as the diagnostic and therapeutic procedures for elderly patients. Further studies are necessary to search for the short-and long-term outcome of elderly hyponatremic patients, particularly if it is possible to treat hyponatremia in an effective way.
